| 1 | Alphabet Inc | 31 127 | 9 M $ | |
| 2 | ASE Technology Holding Co Ltd | 179 512 | 3,9 M $ | |
| 3 | Ionis Pharmaceuticals Inc | 38 988 | 2,9 M $ | |
| 4 | Neurocrine Biosciences Inc | 21 556 | 2,8 M $ | |
| 5 | Axsome Therapeutics Inc | 16 401 | 2,8 M $ | |
| 6 | BioMarin Pharmaceutical Inc | 48 719 | 2,8 M $ | |
| 7 | Ascendis Pharma A/S | 11 828 | 2,7 M $ | |
| 8 | PTC Therapeutics Inc | 39 701 | 2,7 M $ | |
| 9 | Pfizer Inc | 71 313 | 2 M $ | |
| 10 | Regeneron Pharmaceuticals, Inc. | 2 502 | 1,9 M $ | |
| 11 | Johnson & Johnson | 7 902 | 1,9 M $ | |
| 12 | Amgen Inc | 4 934 | 1,7 M $ | |
| 13 | Gilead Sciences Inc | 11 961 | 1,7 M $ | |
| 14 | Vertex Pharmaceuticals Inc | 3 412 | 1,5 M $ | |
| 15 | UnitedHealth Group Inc | 5 216 | 1,4 M $ | |
| 16 | Praxis Precision Medicines Inc | 3 855 | 1,2 M $ | |
| 17 | Insmed Inc | 7 018 | 1,1 M $ | |
| 18 | Protagonist Therapeutics Inc | 9 334 | 983,8 k $ | |
| 19 | Belite Bio Inc | 6 004 | 957,3 k $ | |
| 20 | iShares MSCI Taiwan ETF | 12 500 | 886,5 k $ | |
| 21 | Moderna Inc | 17 097 | 868,5 k $ | |
| 22 | Biogen Inc | 4 706 | 862,8 k $ | |
| 23 | Teva Pharmaceutical Industries Ltd | 25 805 | 777,2 k $ | |
| 24 | Revolution Medicines Inc | 7 971 | 775,2 k $ | |
| 25 | State Street Utilities Select Sector SPDR ETF | 16 400 | 752,6 k $ | |
| 26 | Octave Specialty Group Inc | 139 168 | 647,1 k $ | |
| 27 | Twist Bioscience Corp | 13 476 | 640,4 k $ | |
| 28 | Madrigal Pharmaceuticals Inc | 1 192 | 624 k $ | |
| 29 | iShares Trust | 7 100 | 615,5 k $ | |
| 30 | BioNTech SE | 6 890 | 612,4 k $ | |
| 31 | Natera Inc | 2 970 | 594 k $ | |
| 32 | Axogen Inc | 16 273 | 539,1 k $ | |
| 33 | Select Sector Spdr Trust | 3 300 | 533,7 k $ | |
| 34 | Cogent Biosciences Inc | 13 784 | 530,5 k $ | |
| 35 | Select Sector Spdr Trust | 8 500 | 520,7 k $ | |
| 36 | Select Sector Spdr Trust | 6 300 | 516,5 k $ | |
| 37 | Cytokinetics Inc | 7 388 | 486,9 k $ | |
| 38 | Genmab A/S | 16 030 | 430,1 k $ | |
| 39 | Bridgebio Pharma Inc | 5 785 | 429,6 k $ | |
| 40 | Tango Therapeutics Inc | 20 463 | 428,1 k $ | |
| 41 | Cooper Cos Inc/The | 5 896 | 421,6 k $ | |
| 42 | Eli Lilly & Co | 442 | 406,5 k $ | |
| 43 | Erasca Inc | 24 847 | 402 k $ | |
| 44 | Lumentum Holdings Inc | 562 | 395 k $ | |
| 45 | Illumina Inc | 3 026 | 373 k $ | |
| 46 | BioAge Labs Inc | 20 796 | 363,7 k $ | |
| 47 | Apogee Therapeutics Inc | 4 007 | 337,3 k $ | |
| 48 | ImmunityBio Inc | 41 005 | 314,5 k $ | |
| 49 | United Therapeutics Corp | 527 | 312,5 k $ | |
| 50 | Dyne Therapeutics Inc | 17 213 | 312,1 k $ | |
| 51 | Spyre Therapeutics Inc | 6 140 | 309,7 k $ | |
| 52 | Tyra Biosciences Inc | 8 075 | 309,3 k $ | |
| 53 | Select Sector Spdr Trust | 6 200 | 306,1 k $ | |
| 54 | State Street SPDR S&P 500 ETF Trust | 420 | 273,1 k $ | |
| 55 | Alumis Inc | 12 031 | 265 k $ | |
| 56 | Oruka Therapeutics Inc | 5 147 | 252,5 k $ | |
| 57 | Equitable Holdings Inc | 6 794 | 252,1 k $ | |
| 58 | Franklin Templeton ETF Trust | 3 700 | 252 k $ | |
| 59 | Summit Therapeutics Inc | 12 136 | 230,1 k $ | |
| 60 | Envista Holdings Corp | 9 001 | 228,4 k $ | |
| 61 | CG oncology Inc | 3 370 | 228,1 k $ | |
| 62 | Dexcom Inc | 3 628 | 227,8 k $ | |
| 63 | Nektar Therapeutics | 2 830 | 203,6 k $ | |
| 64 | Structure Therapeutics Inc | 4 190 | 202 k $ | |
| 65 | Verastem Inc | 36 170 | 191,7 k $ | |
| 66 | VanEck Gold Miners ETF/USA | 2 000 | 183,5 k $ | |
| 67 | Climb Bio Inc | 24 590 | 168,4 k $ | |
| 68 | United States Antimony Corp | 11 426 | 99,7 k $ | |
| 69 | Alphabet Inc | 300 | 86,1 k $ | |
| 70 | Iovance Biotherapeutics Inc | 19 760 | 69,4 k $ | |
| 71 | Neumora Therapeutics Inc | 16 000 | 31,2 k $ | |
| 72 | Brandywine Realty Trust | 10 700 | 29 k $ | |
| 73 | SELECT SECTOR SPDR TRUST (THE) | 200 | 26,6 k $ | |
| 74 | Plug Power Inc | 11 208 | 25,3 k $ | |
| 75 | iShares Trust | 500 | 23,4 k $ | |
| 76 | KraneShares CSI China Internet ETF | 400 | 11,4 k $ | |